Cytosorbents Corp (CTSO) is a publicly traded company in the Unknown sector. Across all available filings, 16 corporate insiders have executed 389 transactions totaling $7.5M, demonstrating a bearish sentiment with -$5.3M in net insider flow. The most recent transaction on Nov 18, 2025 involved a transaction of 100,000 shares valued at $64.0K.
No significant insider buying has been recorded for CTSO in the recent period.
No significant insider selling has been recorded for CTSO in the recent period.
Based on recent SEC filings, insider sentiment for CTSO is bearish with an Insider Alignment Score of 14/100 and a net flow of -$5.3M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at Cytosorbents Corp (CTSO) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 16 insiders are actively trading CTSO stock, having executed 389 transactions in the past 90 days. The most active insider is Vincent Capponi (Executive), who has made 64 transactions totaling $3.3M.
Get notified when executives and directors at CTSO file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Nov 18, 2025 | P. Chan Phillip | Executive | Award | 100,000 | $0.64 | $64.0K | |
| Aug 8, 2025 | Deliargyris Efthymios | Executive | Award | 70,000 | $N/A | $0 | |
| Aug 8, 2025 | Capponi Vincent | Executive | Award | 89,100 | $N/A | $0 | |
| Aug 8, 2025 | J. Mariani Peter | Executive | Award | 71,500 | $N/A | $0 | |
| Aug 8, 2025 | P. Chan Phillip | Executive | Award | 105,600 | $N/A | $0 | |
| Aug 14, 2024 | J. Mariani Peter | Executive | Award | 110,000 | $N/A | $0 | |
| Aug 14, 2024 | J. Mariani Peter | Executive | Award | 65,000 | $N/A | $0 | |
| Aug 14, 2024 | J. Mariani Peter | Executive | Award | 175,000 | $N/A | $0 | |
| Apr 2, 2024 | P. Chan Phillip | Executive | Award | 96,000 | $N/A | $0 | |
| Apr 2, 2024 | Capponi Vincent | Executive | Award | 81,000 | $N/A | $0 | |
| Apr 2, 2024 | P. Bloch Kathleen | Executive | Award | 65,000 | $N/A | $0 | |
| Apr 2, 2024 | Deliargyris Efthymios | Executive | Award | 61,000 | $N/A | $0 | |
| Dec 13, 2023 | P. Chan Phillip | Executive | Purchase | 75,188 | $1.33 | $100.0K | |
| Dec 13, 2023 | Kim Jiny | Executive | Purchase | 7,519 | $1.33 | $10.0K | |
| Dec 13, 2023 | P. Bloch Kathleen | Executive | Purchase | 37,594 | $1.33 | $50.0K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 111 | $6.4M | 50.0% |
Exercise(M) | 105 | $2.7M | 21.3% |
Award(A) | 83 | $2.1M | 16.3% |
Purchase(P) | 70 | $1.1M | 8.3% |
Payment(F) | 3 | $479.4K | 3.7% |
Exercise (Options)(X) | 4 | $40.0K | 0.3% |
Gift(G) | 3 | $0 | 0.0% |
Other(J) | 5 | $0 | 0.0% |
Conversion(C) | 5 | $0 | 0.0% |
Insider selling pressure at Cytosorbents Corp has increased, with 16 insiders executing 389 transactions across all time. Total sales of $6.4M significantly outpace purchases of $1.1M, resulting in a net outflow of $5.3M. This selling activity appears largely discretionary, which may warrant closer attention from investors.